Odyssean, LLC reported 474 positions worth $604.68M for the quarter ended Jun 30, 2026, up 131.2% on the prior quarter. It opened 163 new positions, added to 186, trimmed 29 and exited 88. Its largest holding is Ultragenyx Pharmaceutical Inc. at 0.7% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| CLDX Celldex Therapeutics, Inc. | +95.1K | – | $3.54M | 0.585% |
| DASH DoorDash, Inc. | +18.9K | – | $3.49M | 0.577% |
| MEDP Medpace Holdings, Inc. | +6,361 | – | $3.37M | 0.557% |
| NU Nu Holdings Ltd. | +243.9K | – | $3.26M | 0.539% |
| IDYA IDEAYA Biosciences, Inc. | +87.3K | +571.6% | $3.25M | 0.632% |
| DNLI Denali Therapeutics Inc. | +125.1K | – | $3.22M | 0.532% |
| YELP Yelp Inc | +128.7K | – | $3.16M | 0.522% |
| BBIO BridgeBio Pharma, Inc. | +41.0K | – | $3.05M | 0.505% |
| VNO Vornado Realty Trust | +77.7K | – | $3.05M | 0.505% |
| V Visa Inc. | +8,866 | – | $3.04M | 0.503% |
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals, Inc. | -1,957 | -100.0% | $1.51M | Exited |
| NLY Annaly Capital Management Inc | -65.2K | -100.0% | $1.38M | Exited |
| CPT Camden Property Trust | -13.8K | -100.0% | $1.35M | Exited |
| AMZN Amazon Com Inc | -4,502 | -65.8% | $1.07M | 0.092% |
| CELC Celcuity Inc. | -8,856 | -100.0% | $1.01M | Exited |
| ZS Zscaler, Inc. | -7,067 | -100.0% | $991.43K | Exited |
| LBTYA Liberty Global Ltd. | -76.3K | -100.0% | $922.48K | Exited |
| WMT Walmart Inc. | -6,124 | -100.0% | $761.09K | Exited |
| COST Costco Wholesale Corp | -750 | -100.0% | $747.32K | Exited |
| NWE NorthWestern Energy Group, Inc. | -11.1K | -100.0% | $734.11K | Exited |
| Holding | Shares | Trade Value | Weight |
|---|---|---|---|
| CLDX Celldex Therapeutics, Inc. | +95.1K | $3.54M | 0.585% |
| DASH DoorDash, Inc. | +18.9K | $3.49M | 0.577% |
| MEDP Medpace Holdings, Inc. | +6,361 | $3.37M | 0.557% |
| NU Nu Holdings Ltd. | +243.9K | $3.26M | 0.539% |
| DNLI Denali Therapeutics Inc. | +125.1K | $3.22M | 0.532% |
| YELP Yelp Inc | +128.7K | $3.16M | 0.522% |
| BBIO BridgeBio Pharma, Inc. | +41.0K | $3.05M | 0.505% |
| VNO Vornado Realty Trust | +77.7K | $3.05M | 0.505% |
| V Visa Inc. | +8,866 | $3.04M | 0.503% |
| WTRG Essential Utilities, Inc. | +79.3K | $3.04M | 0.502% |
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| REGN Regeneron Pharmaceuticals, Inc. | -1,957 | $1.51M | 0.578% |
| NLY Annaly Capital Management Inc | -65.2K | $1.38M | 0.527% |
| CPT Camden Property Trust | -13.8K | $1.35M | 0.515% |
| CELC Celcuity Inc. | -8,856 | $1.01M | 0.386% |
| ZS Zscaler, Inc. | -7,067 | $991.43K | 0.379% |
| LBTYA Liberty Global Ltd. | -76.3K | $922.48K | 0.353% |
| WMT Walmart Inc. | -6,124 | $761.09K | 0.291% |
| COST Costco Wholesale Corp | -750 | $747.32K | 0.286% |
| NWE NorthWestern Energy Group, Inc. | -11.1K | $734.11K | 0.281% |
| CUZ Cousins Properties Inc | -30.7K | $691.77K | 0.264% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | RARE Ultragenyx Pharmaceutical Inc. | Healthcare | 122.1K | $4.08M | 0.674% | +54.7K | +81.1% | Added | 0.12% |
| 2 | KYMR Kymera Therapeutics, Inc. | Healthcare | 34.5K | $3.95M | 0.654% | +19.7K | +132.7% | Added | 0.04% |
| 3 | IDYA IDEAYA Biosciences, Inc. | Healthcare | 102.6K | $3.82M | 0.632% | +87.3K | +571.6% | Added | 0.11% |
| 4 | PCVX Vaxcyte, Inc. | Healthcare | 62.6K | $3.64M | 0.602% | +42.5K | +211.5% | Added | 0.04% |
| 5 | AFRM Affirm Holdings, Inc. | Financial Services | 44.0K | $3.59M | 0.593% | +25.6K | +139.1% | Added | 0.01% |
| 6 | CLDX Celldex Therapeutics, Inc. | Healthcare | 95.1K | $3.54M | 0.585% | +95.1K | – | New | 0.12% |
| 7 | LOAR Loar Holdings Inc. | Industrials | 43.7K | $3.52M | 0.582% | +23.0K | +111.3% | Added | 0.05% |
| 8 | MIRM Mirum Pharmaceuticals, Inc. | Healthcare | 29.9K | $3.50M | 0.579% | +18.0K | +149.9% | Added | 0.05% |
| 9 | DASH DoorDash, Inc. | Technology | 18.9K | $3.49M | 0.577% | +18.9K | – | New | 0% |
| 10 | KRYS Krystal Biotech, Inc. | Healthcare | 9,349 | $3.47M | 0.575% | +4,530 | +94.0% | Added | 0.03% |
| 11 | VIK Viking Holdings Ltd | Consumer Discretionary | 32.2K | $3.37M | 0.558% | +11.5K | +55.3% | Added | 0.01% |
| 12 | MEDP Medpace Holdings, Inc. | Healthcare | 6,361 | $3.37M | 0.557% | +6,361 | – | New | 0.02% |
| 13 | TOST Toast, Inc. | Technology | 119.8K | $3.33M | 0.551% | +70.7K | +144.1% | Added | 0.02% |
| 14 | AHR American Healthcare REIT, Inc. | Real Estate | 63.5K | $3.31M | 0.548% | +34.8K | +121.1% | Added | 0.03% |
| 15 | NIC Nicolet Bankshares Inc | Financial Services | 20.0K | $3.31M | 0.547% | +10.1K | +101.0% | Added | 0.09% |
Tip. Select a row to see that position’s full history at Odyssean.
As of its Q2 2026 13F filing, Odyssean, LLC’s five largest positions were Ultragenyx Pharmaceutical Inc. (RARE) at 0.7%, Kymera Therapeutics, Inc. (KYMR) at 0.7%, IDEAYA Biosciences, Inc. (IDYA) at 0.6%, Vaxcyte, Inc. (PCVX) at 0.6%, Affirm Holdings, Inc. (AFRM) at 0.6% of the reported portfolio.
Odyssean, LLC reported a 13F portfolio worth $604.68M across 474 positions for Q2 2026. That is up 131.2% from the previous quarter.
Its largest purchases by value were Celldex Therapeutics, Inc. ($3.54M), DoorDash, Inc. ($3.49M), Medpace Holdings, Inc. ($3.37M). It opened 163 new positions.
Its largest sales by value were Regeneron Pharmaceuticals, Inc. ($1.51M), Annaly Capital Management Inc ($1.38M), Camden Property Trust ($1.35M). It exited 88 positions entirely.
From the Form 13F-HR reports Odyssean, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.